WorkflowRegulatory Affairs

The complete guide · November 2026

EU MDR technical documentation review, explained.

To sell a medical device in Europe, a maker must give an outside assessor, called a notified body, a file proving the device is safe and works, and that file can run to thousands of pages. Before it goes in, someone at the company reads it against the law, line by line, looking for missing proof, old standards and any fact that two documents state differently. That read is the technical documentation review, and many makers must finish theirs soon, because older certificates stop counting at the end of 2027 or 2028.

This guide is for anyone who writes, reviews, signs or pays for a technical file: regulatory affairs leads, technical file authors, design engineers, quality managers, heads of regulatory affairs, and the leaders deciding whether to automate the read. No background needed.

See one case, screen by screen →
Watch with transcript →
A quick example · fictional

Imagine you are the regulatory affairs lead at a coronary device maker in the Netherlands. It is Tuesday, October 13, 2026. Your balloon catheter, Calvera NC, is a class III device, the highest risk class, still sold on a certificate from the old EU directive. It needs a new certificate by December 31, 2027, and the file goes to the notified body on November 30. It runs to 186 documents and 9,412 pages.

The last time your company sent in a sister device, the assessor came back with 61 questions over three rounds and 11 months. Now you open the specification, DS-114, at page 12: shelf life, 36 months. Then the label artwork, LA-0388, at panel 2: use-by is the date of manufacture plus 24 months.

Specification DS-114 rev C, p. 12
Shelf life
36 months
Basis
Aging report TR-2291
Changed by
CR-0412, March 2025
Label artwork LA-0388 rev B, panel 2
Use-by rule
+ 24 months
Lot 260914A prints
2028-09
Released
January 14, 2025
Three documents say 24 monthsSix say 36and each one reads as correct on its own.

The change record that extended the shelf life in March 2025 listed the specification, the manufacturing description and the checklist as affected. It left out the label and the instructions for use, so nobody opened them. Your reviewer, reading one document at a time for six weeks, might never set the two pages side by side. A notified body specialist would: on the sister device, question 14 asked for exactly this.

A careful review finds the label that never caught up and fixes it through the company's formal change process, called change control, before the assessor writes the question.

EU MDR technical documentation review guide
Part A · Understand it

MDR technical documentation: Annex II, the GSPR checklist, legacy deadlines and what a notified body asks

What the file is, the rules and their dates as of November 2026, how a checklist line earns its place, why editions and duplicated facts cause so many questions, and what the delay costs, explained without selling anything. If you are new to device regulation, start here.

01 · In plain words

A technical file explained: the proof a device is safe, and the read before anyone outside sees it

A catheter that opens a blocked heart artery cannot go on sale in Europe on its maker's word. The maker must show, in writing, that it meets a long list of safety and performance requirements. That list sits in Annex I of the EU's Medical Device Regulation, known as the MDR. The people in this field call the list the GSPRs, short for general safety and performance requirements.1

The written proof is the technical documentation, usually called the technical file. Annex II of the same regulation says what it must hold: what the device is, what the label and instructions say, how it is designed and made, which requirements apply, how risks were weighed, and the test and clinical evidence. The regulation asks for all of this in a "clear, organised, readily searchable and unambiguous manner".1,2

For most devices above the lowest risk class, an independent organization called a notified body reads the file and audits the company. If it is satisfied, it issues a certificate, and the maker can place the CE mark, the sign that a product meets EU rules, on the device. The notified body's specialists read mostly from their own desks: "Expert reviews of technical documentation (TD) are performed off-site, often by several specialists".3 Whatever they cannot find or cannot square becomes a written question, and the clock keeps running while the company answers.

So careful makers read the file first. A regulatory affairs lead walks a checklist, one Annex I line at a time, and looks for the document and page that meets each line. That read is the subject of this guide. The hard part is scale, because the errors that cost the most sit between documents. A shelf life that changed in the design file and not on the label is invisible to anyone reading one document at a time.

One catheter file, from design records to an MDR certificate

  1. Departments write the evidenceDesign, labeling, manufacturing, test labs and clinical affairs each release documents on their own schedule. Calvera NC has 186 of them.
  2. An author assembles the fileEverything is sorted into the sections of Annex II, and the GSPR checklist is filled in against the company's template: 181 lines.
  3. The regulatory lead reviews itEvery applicable line is tied to a document and page, editions are checked, and facts are compared. Here the 36 and the 24 are caught, or they go out to the assessor.
  4. The notified body assesses itA completeness check, then specialists, then questions in rounds. Calvera SC, the sister device, took 3 rounds and 61 questions.
  5. The certificate arrives, or the date passesThe certificate is needed by December 31, 2027. Without it, new supply into the EU stops on that date.

Step 3 is the subject of this guide. The company, device and figures in this example are fictional.

Why a file with good evidence still draws questions, and three more surprises

The law never says "checklist"

Annex II section 4 asks which requirements apply, why the others do not, the methods used, the standards applied, and the precise identity of the controlled documents, meaning those under formal version control. A table became the usual answer, and no official template exists.1,2

Good testing does not settle it

Team-NB, the notified bodies' association, says "a simple collection of test/verification reports does not fulfil this requirement". The file must show how each requirement is met.2

Only about one in four notified bodies calls most files complete

14 of 52 notified bodies say more than half of the submissions they receive are complete without a request for more information, as of February 2026.4

Standard editions move with no notice to you

Harmonized standards are the European standards the EU lists as a recognized way to meet its requirements. The list was set up in July 2021 and amended ten times by June 2026, three of those in the first half of 2026. Nothing tells a maker when it changes.5

GSPR, technical file, notified body, legacy device

GSPR

General safety and performance requirement: one of the duties in Annex I of the MDR, grouped in 23 numbered sections.

Technical file

The technical documentation of Annex II: the maker's full written proof that one device meets those requirements.

Notified body

An independent organization designated by an EU country to assess devices and issue certificates. 52 were designated under the MDR in February 2026.4

Legacy device

A device still sold on a certificate from the old directives, allowed by the MDR's transition rules while its conditions hold.6

The MDR sorts devices into four risk classes: I, the lowest, then IIa, IIb and III, the highest. Fourteen terms are defined in the one-page summary.

02 · Annex II and Annex I

What the MDR technical file contains: six Annex II sections set against 23 Annex I sections

In shortAnnex I says what a device must achieve. Annex II says how to prove it. A review reads the second against the first. The proof sits in documents written by many departments, so the person who assembles the file owns almost none of the underlying work and answers for all of it.

Annex II sectionWhat it holdsWho usually writes it
1. Device description and specificationWhat the device is, variants, accessories, materials, the Basic UDI-DI (the identifier of the device family), the risk class and the rule behind itDesign engineering, regulatory affairs
2. Information supplied by the manufacturerEvery label and packaging level, and the instructions for use (IFU) in each language of saleLabeling, technical file author
3. Design and manufacturing informationDesign stages, processes and their validation, sites, suppliers and subcontractorsManufacturing, purchasing
4. General safety and performance requirementsThe checklist: which apply, why others do not, the method, the standard, the documentRegulatory affairs
5. Benefit-risk analysis and risk managementThe benefit-risk analysis and the results of risk managementRisk management, clinical
6. Product verification and validationBench and lab reports, biological evaluation, stability and shelf life, the clinical evaluation, and extra data for sterile supply and other special casesTest labs, design, clinical affairs

Regulation (EU) 2017/745, Annex II.1 Annex III adds post-market documentation, which sits outside this guide.

More than half of a class III file's pages are pre-clinical and clinical data

Pages in the fictional Calvera NC file, 9,412 in all, by Annex II section

§6.1 Pre-clinical and clinical data84 documents5,402 pages
§3 Design and manufacturing38 documents1,566 pages
§2 Labels and instructions31 documents1,048 pages
§1 Device description14 documents612 pages
§5 Benefit-risk and risk management9 documents388 pages
§6.2 Sterile supply7 documents322 pages
§4 GSPR checklist3 documents74 pages

Fictional example from this guide

Show the numbers
Annex II sectionPages
§6.1 Pre-clinical and clinical data5,402 pages
§3 Design and manufacturing1,566 pages
§2 Labels and instructions1,048 pages
§1 Device description612 pages
§5 Benefit-risk and risk management388 pages
§6.2 Sterile supply322 pages
§4 GSPR checklist74 pages

A reader's eye lands on the big section, and the biggest section gets the most care. Yet the short ones carry the facts that spread: the 74 pages of the checklist point into everything else, and the labels in section 2 repeat values set in sections 1 and 6.

Annex I: 23 sections in three chapters, most of which apply only to some devices

For a plain balloon catheter, 44% of the checklist does not apply, and each of those lines still needs a reason

The fictional company's 181 checklist lines, split by chapter of Annex I

Applies to this deviceNot applicable, with a reason
Chapter I, general (sections 1 to 9)223
Chapter II, design and manufacture (10 to 22)4070
Chapter III, label and instructions (23)406

Fictional example from this guide

Show the numbers
ChapterApplies to this deviceNot applicable, with a reason
Chapter I, general (sections 1 to 9)223
Chapter II, design and manufacture (10 to 22)4070
Chapter III, label and instructions (23)406

Chapter I holds the general duties: performance, risk reduction, risk management, use error, lifetime, transport and storage. Chapter II covers chemical and biological properties, infection, construction, software, active devices and more. Chapter III is one long section on the label and the instructions for use.1 Sections such as radiation and software simply do not apply to a plain catheter, which is why 79 of the 181 lines on this example are marked not applicable.

181 is a choice. How many lines the 23 sections become depends on how a company splits them. The regulation sets no line count, so a count describes only a company's template. The example's company uses template version 5. Another maker of the same device could choose far more or far fewer.
03 · The rules and their dates

The MDR transition rules, and what changed for technical files between 2023 and 2026

Status as of November 2026

In shortThe MDR has applied since May 26, 2021. A 2023 amendment extended the transition for older certificates to the end of 2027 or 2028, on conditions. In 2026 the notified bodies' guidance reached Version 4, the harmonized list moved three times, and the EU's device database, EUDAMED, became mandatory. The Commission's December 2025 reform proposal remains a proposal.

Two transition dates remain, and three 2026 changes already affect a file being reviewed today
  1. May 26, 2021MDR applies

    Regulation (EU) 2017/745 replaces the old directives.

  2. Mar 20, 2023Transition extended

    Regulation (EU) 2023/607 takes effect and removes the last date for selling units already on the market.

  3. Sep 26, 2024Last written agreement

    Application by May 26, 2024, agreement by this date, or the device leaves the transition.

  4. Dec 16, 2025Reform proposed

    The Commission's proposal, COM(2025) 1023, goes to Parliament and Council.

  5. Apr 21, 2026Team-NB Version 4

    New best practice guidance on technical documentation, with more common pitfalls.

  6. May 28, 2026EUDAMED mandatory

    Four database modules become compulsory, device registration among them.

  7. Jun 17, 2026EN ISO 10993-1:2025 listed

    Decision (EU) 2026/1231 updates the harmonized list.

  8. Nov 28, 2026Legacy registration

    EUDAMED registration deadline for devices, legacy ones included, first sold before May 28, 2026 with more units to follow.

Source 1,7,8,2,9,10,11,12,13

Show the numbers
WhenWhat
May 26, 2021MDR applies
Mar 20, 2023Transition extended
Sep 26, 2024Last written agreement
Dec 16, 2025Reform proposed
Apr 21, 2026Team-NB Version 4
May 28, 2026EUDAMED mandatory
Jun 17, 2026EN ISO 10993-1:2025 listed
Nov 28, 2026Legacy registration
Dec 31, 2027First deadline
Dec 31, 2028Second deadline
TextWhat it asks of a technical fileStatus
MDR Annexes I and IIThe requirements, and the file that proves them, down to "the precise identity of the controlled documents".1In force
MDR Article 15A named person responsible for regulatory compliance makes sure the documentation and the declaration of conformity, the maker's formal statement that the device meets the law, are drawn up and kept up to date.14In force
Regulation (EU) 2023/607Dates and five conditions for legacy devices; no significant change in design or intended purpose.7,8In force
MDCG 2020-3 Rev.1Which changes count as significant for a legacy device, by chart.6Current guidance
MDCG 2021-5 Rev.1How harmonized standards work, and that the most recent editions reflect the state of the art.15July 2024, current
Harmonized standards listWhich references give presumption of conformity: a file that follows the standard is taken to meet the requirements it covers. Use stays voluntary.5,9Latest decision June 11, 2026, with a corrigendum
Team-NB guidanceHow notified bodies want a file built, with lists of common pitfalls.2Version 4, April 21, 2026; not binding
EUDAMEDRegistered device data, which must agree with the file and the label.12,13Mandatory from May 28, 2026

MDCG is the Medical Device Coordination Group, made up of the EU countries' device authorities. It publishes the guidance cited throughout this guide.

A claim to correct. Posts about the December 2025 proposal often describe its changes as coming. It would, among other things, remove the five-year limit on certificates, reduce technical documentation assessment for lower and medium risk devices, and allow machine-readable digital files. As of November 2026 Parliament's file reads "Awaiting committee decision", with an indicative plenary date of December 14, 2026 and no Council position recorded. Plan on the law as it stands.10,11
04 · Legacy device deadlines

MDR legacy devices: which deadline applies, the five conditions, and what a shelf-life change can break

In shortA legacy device may stay on sale until December 31, 2027 or 2028 while five conditions hold. Two of those carried 2024 dates that have passed, and what they put in place must stay in place. The one a file review can break is "no significant changes in the design and intended purpose", and it reaches the repair work on the file, known as remediation: correcting a shelf life on a label can count as a significant change unless the notified body approved the protocol behind it.

DeviceLast day to place on the market as a legacy device
All class IIIDecember 31, 2027
Class IIb implantable, except sutures, staples, dental fillings, braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectorsDecember 31, 2027
Those excepted class IIb implantables, other class IIb, class IIaDecember 31, 2028
Class I placed on the market sterile or with a measuring functionDecember 31, 2028
Self-declared class I up-classified by the MDR, declaration drawn up before May 26, 2021December 31, 2028

Article 120(3a) and (3b), as amended by Regulation (EU) 2023/607.7,8

Five conditions for staying on sale: three still running, two dated in 2024

Continuing

Still meets the directive

The device keeps complying with the directive it was certified under.8

Continuing, and a file fix can break it

No significant change

No significant change in design or intended purpose. MDCG 2020-3 walks this through a main chart and five more.6

Continuing

No unacceptable risk

The device does not present an unacceptable risk to health or safety.8

Dated May 26, 2024

Quality system in place

A quality management system under Article 10(9) by that date.8

Dated 2024

Application, then agreement

A formal application by May 26, 2024, and a written agreement by September 26, 2024. Withdrawing the application or ending the agreement ends the transition, unless the application moves to another notified body under a new agreement.8

Correcting a label can itself be a significant change

SubjectListed as significantListed as non-significant
Shelf life"extension of the (labelled) shelf life which is not validated against protocols approved by" the notified body"extension of the shelf life validated by protocols approved by the notified body"
SterilizationA change of terminal sterilization methodChanged cycle parameters; a new vendor or chamber. Valid only with no impact on sterility assurance level or residuals
Intended purposeNew indications, new patient population, new userRestricting or deleting an indication

MDCG 2020-3 Rev.1, sections on intended purpose and sterilization, chart E.6 Wording shortened; read the charts for your own change.

What this means for the example. The company has an aging report that supports 36 months and a label that prints 24. Moving the label to 36 is the obvious fix. For a legacy device it is safe only once someone confirms the notified body approved the aging protocol. If it did not, the guidance lists the extension as significant, and a significant change ends the transition for that device. A sound review records that check in the change record before the artwork moves.6

Counting back from December 31, 2027

A November 2026 submission clears the 2027 deadline only at the fast end of what notified bodies report

Months from the planned submission of the fictional Calvera NC file, using the survey's bands as a planning assumption

13 to 18 months, 51% of notified bodies19 to 24 months, 31%
Fastest of the 13-18 month band
Slowest of the 13-18 month band
Fastest of the 19-24 month band
Slowest of the 19-24 month band
Nov 2026Dec 2027Nov 2028

Fictional example from this guide · The survey clock starts at the written agreement, which for a legacy device was signed by September 26, 2024, so a real assessment may already be under way. Ask your notified body for your own dates.

Show the numbers
ActivityFromTo
Fastest of the 13-18 month band013
Slowest of the 13-18 month band018
Fastest of the 19-24 month band019
Slowest of the 19-24 month band024

A legacy device's written agreement could be two years old by now, because a company may have signed to protect the transition and sent the product file later. So the survey bands cannot date your certificate. Put one question to your notified body: given where the file stands today, when could this certificate issue?4,8

What the deadline stops. The date ends the placing of new units on the market on the strength of the old certificate. Units already placed on the market "may continue to be made available on the market or put into service without any limitation in time without prejudice to the device's possible shelf-life or expiry date". Distributor stock survives; the factory's shipments into the EU do not.8
05 · The GSPR checklist

How to fill in a GSPR checklist line: requirement, reason, method, standard, and the page that proves it

In shortEach line says whether the requirement applies, why not if it does not, how conformity was shown, under which standard, and which controlled document and page proves it. The last column fails most often. A line naming a document with no page leaves the assessor to search, and a search usually ends in a question.

ColumnWhat it must giveWorked on one line (fictional)
RequirementThe Annex I text and its number; split long ones, drop nothingAnnex I section 23.2, what the label must carry: the time limit for using the device safely1
Applies, and why notYes or no for this device and intended purpose, with a written reason for each noApplies: supplied sterile, limited shelf life
MethodAn activity: testing, evaluation, validation, a documented rationaleAccelerated and real-time aging of the sterile barrier and the device; claim carried onto the artwork
Standard or other solutionThe edition, the clauses used, and "full or partial compliance"2EN ISO 15223-1 for the symbol; the aging protocol for the claim
Controlled document, to the page"Document ID, document date, section, point, page, chapter, link"2TR-2291 rev C; DS-114 rev C p. 12; LA-0388 rev B panel 2

The notified bodies say why the last column deserves the effort: "The more specific the references are to documents supporting compliance, the faster the assessment can be conducted."2 Only released documents count: "Draft documents should not be provided".2 A citation to revision B of a report now at revision D points at something a reviewer cannot obtain, so every revision of a widely cited report sends someone back through every line that cites it.

181 lines become 88 proved, on one class III catheter

After the first read, 14 of the 102 lines that apply still have no clean proof

The fictional Calvera NC checklist. The 14 open lines are 11 gaps and 3 lines held open by contradictions

Lines on the company's template181
Lines that apply to this device102
Lines with a document and page88

Fictional example from this guide

Show the numbers
StageLines
Lines on the company's template181
Lines that apply to this device102
Lines with a document and page88

A "not applicable" with a good reason, and one that is a gap in disguise

Holds up

"Not applicable: not an active device; inflation is by a separate manual inflation device." The reason rests on a property of the device, so it survives a change of indication.

Draws a question

A magnetic resonance safety line marked "not applicable" with nothing beside it. Team-NB lists this one almost word for word: "identified as 'not applicable'; however, no justification/rationale is provided."2 In the example file it is listed as gap G-05.

Where the checklist meets the risk file

Reviewers read these two together. Team-NB asks that verification and validation reports be "linked to the risk IDs indicated in the risk assessment".2 A residual risk, the risk left once every control is in place, that the risk report accepts usually has to reach the user, as a warning, precaution or contraindication, through the label and instructions that Annex I section 23 governs.1 In the example, the risk management report concludes 13 residual risks and the instructions list 11. Reading either document alone shows nothing wrong.

06 · Harmonized standards

Which standard edition to cite in an MDR file: the harmonized list against the state of the art

In shortTwo clocks run at different speeds. The list in the EU's Official Journal says which edition gives you a presumption of conformity. The state of the art says which edition a reviewer measures you against, and it moves when the standard is published. A file citing a superseded edition needs a gap analysis: a written comparison of the two editions and what the difference means for the device.

The MDR harmonized list changed three times in the first half of 2026 alone

Implementing decisions on the list by year, eleven in all, July 2021 to June 2026

12021
22022
12023
22024
22025
32026 to June

Source 5

Show the numbers
YearDecisions
20211
20222
20231
20242
20252
2026 to June3
StandardAn older file often citesCurrent editionOn the MDR list
EN ISO 10993-1, biological evaluation of how a device's materials affect the bodyISO 10993-1:2009EN ISO 10993-1:2025The 2025 edition, since June 17, 2026. No earlier edition of this part was listed.9
EN ISO 15223-1, label symbolsEN ISO 15223-1:2016EN ISO 15223-1:2021 with A1:2025Both 2021 and 2021 with A1:2025. The plain 2021 reference is deleted from June 15, 2031.9
EN ISO 10555-4, balloon dilatation cathetersEN ISO 10555-4:2013EN ISO 10555-4:2023Check the current list. The 2023 European edition supersedes 2013.16
The list gives you

Presumption of conformity with the requirements the standard aims to cover. Use stays voluntary: "choosing to use a standard or not" is the manufacturer's call. Labels are the exception: under Annex I 23.1(h), symbols and identification colors "shall conform to the harmonised standards" where such standards exist.15,5

The state of the art asks for

The most recent editions published by the standards bodies "should be considered as reflecting" the state of the art "regardless of the OJ referencing", the Commission's position as recorded by the coordination group.15

What a file needs when it cites a superseded edition

Nothing happens automatically when a standard is revised. A reviewer reads the report against the current method and asks what the difference means. Team-NB says a key standard not applied in full, a newer version than the harmonized one, or an outdated one each needs "a summary or gap analysis", "a risk analysis and a duly justified conclusion". Its biocompatibility pitfalls include "No gap and impact assessment provided to demonstrate validity of evaluation/test when performed according to outdated standard."2

  1. Find every citation, because the checklist, declaration of conformity, clinical evaluation and risk file often repeat the same edition.
  2. Compare the two editions clause by clause, and say what changed for this device.
  3. Decide: accept with a written rationale, repeat the affected tests, or update the document.
  4. Send it through change control, so the citation and the document move together.
  5. Keep a dated list and re-read it against the Commission's page on a fixed schedule. Monthly fits the pace above.
07 · Facts that disagree

Cross-reading a technical file: shelf life, rated burst pressure and UDI-DI, worked through with numbers

In shortTeam-NB names different information in multiple locations as a common cause of delay and tells makers to keep duplicated facts correct everywhere. Reading a fact across documents finds what a document-by-document read cannot. Three examples, each with its arithmetic: an aging calculation, a burst pressure claim, and a barcode check digit.

Team-NB, Version 4: "There are many areas of the technical documentation that will require the duplication of information for multiple documents such as device description. Please ensure that the information is correct throughout all areas where this information is duplicated and consider the risk of potential errors/inconsistencies when updating (e.g. Basic UDI-DI, UDI-DI, intended use, indications for use, contraindications, warnings, etc.)."2
Eight facts reach 14 documents, across every family of document in the file

The fictional Calvera NC file: how many places state each fact, grouped by document family

NoneOne placeTwo placesThree or more
Design fileLabel and IFURisk, clinicalTest reportsChecklist, declaration, changeClassificationTwo placesNoneTwo placesNoneTwo placesSterilization methodTwo placesTwo placesOne placeThree or moreOne placeShelf lifeTwo placesTwo placesTwo placesOne placeTwo placesUDI-DIOne placeOne placeNoneNoneTwo placesBasic UDI-DIOne placeNoneOne placeNoneTwo placesIntended purposeOne placeOne placeTwo placesOne placeNoneStorage conditionsOne placeTwo placesNoneOne placeNoneRated burst pressureOne placeOne placeTwo placesOne placeNone

Fictional example from this guide · Shading shows the number of places, capped at three. 46 statements in all.

Show the numbers
Design fileLabel and IFURisk, clinicalTest reportsChecklist, declaration, change
ClassificationTwo placesNoneTwo placesNoneTwo places
Sterilization methodTwo placesTwo placesOne placeThree or moreOne place
Shelf lifeTwo placesTwo placesTwo placesOne placeTwo places
UDI-DIOne placeOne placeNoneNoneTwo places
Basic UDI-DIOne placeNoneOne placeNoneTwo places
Intended purposeOne placeOne placeTwo placesOne placeNone
Storage conditionsOne placeTwo placesNoneOne placeNone
Rated burst pressureOne placeOne placeTwo placesOne placeNone

Shelf life: the arithmetic behind 36 months

Accelerated aging keeps packaged devices warm so that a shorter test stands in for years on a shelf. The usual conversion in device files, from ASTM F1980, is an aging factor built from a Q10 value, the assumed rate of change per 10 °C.17 With a Q10 of 2, a chamber at 55 °C and a room at 25 °C:

Aging factor = Q10 ^ ((55 − 25) ÷ 10) = 2³ = 8 · Days in chamber = 36 months (1,095 days) ÷ 8 ≈ 137 days
A hotter chamber shortens the test, and every degree is an assumption the file must defend

Chamber days to represent 36 months at 25 °C, with a Q10 of 2

50 °C (factor 5.7)194 days
55 °C (factor 8), the example's chamber137 days
60 °C (factor 11.3)97 days

Illustrative · replace with your own numbers · Our arithmetic from the formula above. Your Q10 and temperatures need their own justification.

Show the numbers
Chamber temperatureDays
50 °C (factor 5.7)194 days
55 °C (factor 8), the example's chamber137 days
60 °C (factor 11.3)97 days

Four places a 36-month aging claim falls down

WhereWhat Team-NB lists
Storage range"In accelerated aging studies, the upper limit of the claimed storage temperature range is not covered by the calculation"
What was agedStability work may look at the packaging and "does not consider the stability of the device"
Interim points"Without a passing interim result, no shelf life can be supported (0 days), as it remains unclear at which point during storage the product may have failed."
Study timingReal-time and accelerated studies should start at the same time

Team-NB Version 4, common pitfalls.2

A file that passes all of this can still fail on the label, because the number has to reach every document that states it.

Shelf life vs lifetime of a medical device: two claims, two kinds of proof

Shelf lifeLifetime
ClaimHow long the device can be stored and still work safelyHow long it goes on working safely once in use
Where the MDR puts itAnnex II 6.1, stability including shelf lifeAnnex I, general requirements
ProofReal-time and accelerated aging, on packaging and deviceFatigue, wear, repeated use, clinical data where needed
Where the reader sees itThe label, as a use-by dateUsually the instructions for use

Annex I and II; Team-NB lists stability and shelf life under section 6.1.1,2 Team-NB: "it should not be considered that product lifetime is equivalent to shelf life."2

Rated burst pressure: 18 atmospheres in the report, 20 in the doctor's instructions

A balloon catheter's rated burst pressure is the pressure a physician must not exceed. In the example, the specification and bench report give 18 atmospheres (atm), shown at 99.9% reliability with 95% confidence. The instructions' compliance chart, the table of balloon size at each pressure, says 20 atm, because it was rebuilt in 2024 from the sister device's template. A doctor reads the instructions, so the wrong number is the one that reaches the catheter lab. Proving the claim by bursting balloons, with no failures allowed, would take this many:

Zero-failure test at 99.9% reliability, 95% confidence: n = ln(0.05) ÷ ln(0.999) ≈ 2,995 balloons

That figure is our arithmetic and explains why bench reports rarely test that way. Testing a smaller sample to failure and applying statistics takes far fewer units, so the claim rests on a calculation inside report TR-2207, and a template copy can overwrite it unnoticed. EN ISO 10555-4 is the standard for these catheters; its 2023 edition replaced 2013.16

UDI-DI: a check digit that proves one of two numbers wrong

The UDI-DI is the device's identifier in its barcode. A GS1 number ends in a check digit calculated from the others, there to confirm the number's integrity.18 Multiply the digits by 3 and 1 in turn, starting from the right of the first 13, add them up, and the check digit brings the total to a multiple of ten.

WhereNumberWeighted total of the first 13 digitsCheck digit neededPrinted
Label LA-0388095200132204756555, passes
Draft declaration DOC-0388095200132204575917, fails

Fictional numbers; our arithmetic. Team-NB lists "Basic UDI-DI is not consistent across the application, Declaration of Conformity" and other records among its pitfalls.2 With EUDAMED mandatory, the same identifiers now also sit in a public database, so a mismatch has one more place to surface.12,13

08 · What goes wrong

Why technical files come back: incomplete submissions and fourteen pitfalls notified bodies publish

In shortThe causes notified bodies publish are specific, and most concern finding the evidence and making documents agree. Team-NB names incomplete submissions, poor structure and inconsistent information as the most common causes of delay. The Commission's survey shows that incompleteness also ends applications outright.

Roughly one notified body in four says most files arrive complete
27 in 100

notified bodies (14 of 52) say more than half of submissions are complete without a request for more information, February 2026

Source 4

Show the numbers
MeasureValue
notified bodies (14 of 52) say more than half of submissions are complete without a request for more information, February 202627 of 100
One refusal reason in four is an incomplete application

Reasons given for refusing MDR applications, as reported to February 2026. An application can have several reasons

Outside the notified body's designation30%156
Application not complete25%131
Other, such as withdrawal by the customer109
Wrong qualification or classification85
Insufficient notified body resources30
Wrong conformity assessment procedure13

Source 4

Show the numbers
ReasonTimes given
Outside the notified body's designation156
Application not complete131
Other, such as withdrawal by the customer109
Wrong qualification or classification85
Insufficient notified body resources30
Wrong conformity assessment procedure13
WhereWhat notified bodies reportHow a pre-submission read tests it
Whole file"Lack of Cohesive Structure": the information exists "but is difficult to locate"A stranger finds ten random pieces of evidence in a minute each
Whole fileIntended purpose or other key information "presented in multiple locations with different information"Read each key fact from every document that states it
DescriptionVariants and configurations "not very clear or are inconsistent throughout"List variants from the description, label and declaration, then compare
DescriptionThin rationale for classificationRule cited, reason written
Labels and IFUBasic UDI-DI "assigned incorrectly" or inconsistentCheck digit and a cross-read
Labels and IFUIFU missing 23.4 items, such as compatible devices and links to the summary of safety and clinical performanceWalk section 23 one letter at a time
Labels and IFUIntended use and indications used interchangeablyCompare wording with MDCG 2020-6 definitions
Checklist"Not applicable" with no rationaleNo blank reason survives
ChecklistNo "clear and unambiguous reference" to the evidenceEvery line has a page
ChecklistNo justification for partial use of a standardFull or partial stated, clauses named
Biological evaluationNo gap assessment for an outdated standardEdition check across the file
Packaging and agingInterim time points undefined; storage limit not covered; label legibility after aging not checkedRead the protocol against the label claim
Reports"Abbreviated or partial test reports are not considered acceptable"Completeness of each report, then its revision
TranslationsPoor translations "lead to additional questions", and at worst "a negative recommendation"Translation index against each language of sale

Quotations from Team-NB Version 4, sections on general considerations and common pitfalls.2 The third column is ours. Notified body reviews "often reveal inconsistencies of the intended purpose in application documents", in the words of an account co-written from inside one.3

Why careful reviewers miss a value that changed in one document

A reviewer reads documents in order, and each document here is correct on its own terms. The specification was approved. The label was approved. The fault exists only in the relationship between them, and that relationship appears on no page. The change record is the usual cause: someone answers "which documents state this number?" from memory, and the people in the room own the design file. Answering from memory misses the artwork, the instructions or the risk report.

Three of the example's nine shelf-life statements were left behind by one change record

Where the fictional file states its shelf life

Say 36 months: 6Say 24 months: 3
9places
  • Say 36 months6
  • Say 24 months3

Fictional example from this guide · 36 months: specification, manufacturing description, aging report, clinical evaluation, change record, checklist. 24 months: label artwork, instructions for use, risk report.

Show the numbers
PartValue
Say 36 months6
Say 24 months3
09 · Timing and cost

How long MDR certification takes and what it costs: the published numbers behind a late file

In shortHalf of the notified bodies that have issued one report 13 to 18 months for a new certificate covering the quality system and the product, and four in ten report longer. Fees are a small part of the bill: manufacturers report full costs several times higher, and the Commission's evaluation says the gap is their own compliance work. No one publishes the cost of a round of questions.

Half of notified bodies report 13 to 18 months, and four in ten report longer

Share of notified bodies giving each band for a new MDR certificate covering the quality system and the product, written agreement to issue, February 2026

Under 6 months0%
6 to 12 months8%
13 to 18 months51%
19 to 24 months31%
Over 24 months10%

Source 4 · Data of 39 notified bodies; 13 others had issued no such certificate yet.

Show the numbers
TimeNotified bodies
Under 6 months0%
6 to 12 months8%
13 to 18 months51%
19 to 24 months31%
Over 24 months10%

A journal account co-written by a notified body specialist agrees: "Data collected in summer 2024 show MDR product certifications take in 75% of all cases more than a year".3 These durations include the maker's own time on questions, and nobody publishes how much. A claim that 58% of that time sits with the manufacturer circulates in trade summaries, drawn from an older survey. We could not find it in the February 2026 data, so treat it with care.

MDR certificates keep climbing and still trail applications

Certificates keep climbing and still trail applications, with 18,010 issued against 32,898 filed

Running totals under the MDR, by survey date

Applications filedCertificates issued
010,00020,00030,00040,00032,89818,010
Feb 2024Oct 2024Jun 2025Feb 2026

Source 4 · One application can correspond to more than one certificate. The February 2026 fall in applications reflects a change in how a few bodies count.

Show the numbers
Applications filedCertificates issued
Feb 202420,4246,978
Oct 202428,03710,497
Jun 202532,92014,831
Feb 202632,89818,010

What a product certificate costs, against what the notified body charges

Manufacturers report costs several times the notified body's fee

Average reported, product certificates under Annex IX Chapter II (technical documentation assessment), in euros as published

Fee reported by notified bodiesFull cost reported by manufacturers
First certificate75,532 euros616,981 euros
Most recent certificate68,309 euros385,617 euros
Yearly upkeep16,571 euros48,503 euros

Source 19 · Two different surveys, 14, 33 and 31 manufacturer respondents. The full cost includes technical documentation, clinical data and staff. Read the gap as indicative.

Show the numbers
Fee reported by notified bodiesFull cost reported by manufacturers
First certificate75,532 euros616,981 euros
Most recent certificate68,309 euros385,617 euros
Yearly upkeep16,571 euros48,503 euros

In dollars at $1.1216 per euro, that is about $692,000 against $84,700 for a first certificate.19,20 The Commission's evaluation adds that clinical evaluations alone run about €30,000 to €250,000 (about $33,600 to $280,400), and that 112 of 275 contributions to its call for evidence, 40.7%, named notified body capacity limits and long delays as main obstacles.19

What notified bodies publish per hour of file assessment

Five published fee lists put an hour of file assessment anywhere from €195 to €400

Published hourly rates for technical documentation assessment, in euros, taking the top of any stated range

NB 1984, documentation assessment400 euros
NB 1383, class IIb (class III left blank)265 euros
SIQ, a stated minimum250 euros
NB 0425, top of €195 to €225225 euros
NB 1023, with a €20,000 minimum per file200 euros

Source 21,22,23,24,25 · A sample of five, the lists we could read. Article 50 requires each notified body to publish its fees, so read your own.

Show the numbers
Published listPer hour
NB 1984, documentation assessment400 euros
NB 1383, class IIb (class III left blank)265 euros
SIQ, a stated minimum250 euros
NB 0425, top of €195 to €225225 euros
NB 1023, with a €20,000 minimum per file200 euros

The MDR requires these lists, and the coordination group's template tells bodies to name what drives the fee, including the "quality and completeness of the technical documentation, number nonconformities raised and rounds of reviews needed".1,26 One list states that its price "includes a maximum of 1 round of iteration".23 So rounds appear on invoices as well as in calendars.

What nobody publishes. We found no public figure for the cost of a round of questions, the average number of rounds or questions per file, the share of questions caused by inconsistent documents, the hours a pre-submission review takes, or how many errors a manual review misses. Trade figures on these come without a dataset. Part C shows how to find your own.

The European medical technology market behind the notified body queue

38,000+

medical technology companies in Europe, about 90% of them small or medium-sized.10

European Commission, 2025
€170bn

estimated European market in 2024, about $191 billion, with more than 930,000 people employed.10

European Commission, 2025
52

notified bodies designated under the MDR in February 2026, all of whom answered the survey.4

20th notified body survey
10 · Inside the notified body

What happens after you submit a technical file: who reads what, and how one question travels

In shortA notified body checks the application, allocates specialists by subject, assesses the clinical evidence in a report of its own, and leaves the final review and decision to its own employed staff, as the MDR requires. Written questions travel through several desks on both sides, so a small defect can cost weeks.

A class III file passes through six stages, and only the question stage is partly in your hands
  1. 1Application review

    Completeness, classification, route, designation, resources.

    Notified bodyAnnex VII 4.3
  2. 2Specialist review

    Use, biocompatibility, clinical evaluation, risk management, sterilization, off-site.

    SpecialistsAnnex VII 4.5
  3. 3Questions and answers

    Written batches, answers citing released documents only.

    You, then the specialistOpen-ended
  4. 4Clinical assessment

    Clinical evidence, written up as a clinical evaluation assessment report.

    Clinical reviewersAnnex IX Section 4
  5. 5Recommendation

    A project report with a signed recommendation.

    Responsible staffAnnex VII 4.6
  6. 6Final review and decision

    The notified body's own employed staff; this step is never subcontracted.

    Final reviewersAnnex VII 4.7, 4.8

Our reading of the sources 1,3,27

Show the numbers
StepWhat happensWhoTime
Application reviewCompleteness, classification, route, designation, resources.Notified bodyAnnex VII 4.3
Specialist reviewUse, biocompatibility, clinical evaluation, risk management, sterilization, off-site.SpecialistsAnnex VII 4.5
Questions and answersWritten batches, answers citing released documents only.You, then the specialistOpen-ended
Clinical assessmentClinical evidence, written up as a clinical evaluation assessment report.Clinical reviewersAnnex IX Section 4
RecommendationA project report with a signed recommendation.Responsible staffAnnex VII 4.6
Final review and decisionThe notified body's own employed staff; this step is never subcontracted.Final reviewersAnnex VII 4.7, 4.8

Some high-risk devices add an expert panel step. Class III implantables and certain class IIb active devices go through it, with 21 calendar days for a screening panel to say whether it will give an opinion and 60 calendar days to give one.2,28 Coronary dilatation catheters are class III under Rule 6 and are not implantable, so the example's file skips that step.29

One superseded edition, followed from the reviewer's desk and back

Each answer waits on change control, because a reply may cite only a released document
  1. 1Specialist asks

    A report follows a superseded edition. Question goes into the batch.

    SpecialistDay 0
  2. 2Batch is sent

    Consolidated, with a reply date.

    Notified body contactDays
  3. 3Routed inside

    The regulatory lead decides who owns each question.

    Regulatory leadDays
  4. 4Evidence fixed

    Gap analysis or a re-run.

    Design engineerWeeks
  5. 5Released

    The corrected document goes through change control.

    Quality managerWeeks
  6. 6Answered, then re-read

    Reply cites the new revision and page; the specialist joins it back to the queue.

    Regulatory lead, specialistWeeks

Illustrative · replace with your own numbers · The steps follow the roles in Annex VII and Team-NB's guidance. The durations are our illustration; no one publishes them.

Show the numbers
StepWhat happensWhoTime
Specialist asksA report follows a superseded edition. Question goes into the batch.SpecialistDay 0
Batch is sentConsolidated, with a reply date.Notified body contactDays
Routed insideThe regulatory lead decides who owns each question.Regulatory leadDays
Evidence fixedGap analysis or a re-run.Design engineerWeeks
ReleasedThe corrected document goes through change control.Quality managerWeeks
Answered, then re-readReply cites the new revision and page; the specialist joins it back to the queue.Regulatory lead, specialistWeeks
Withdrawals are visible. If a manufacturer withdraws an application once the process has started, the notified body must tell the other notified bodies through EUDAMED, under Article 53(2).27 Submitting early to hold a place in the queue therefore carries a cost that a project plan rarely shows.
11 · Automation and AI

AI on a technical file: what a reader can check, what stays a signature, and which rules apply

In shortReading, mapping and comparing can be automated, because anyone can check a result by opening the cited page. Deciding which value is right, accepting a "not applicable" and signing stay with named people, as Article 15 assumes. Most regulators' AI papers are written for medicines. For device makers, the working tests are what the MDR demands of the file and what ISO 13485, the quality management standard for devices, demands of quality system software.

Automate work that is mechanical and checkable; keep judgment and signatures with people
How large and mechanical the reading is →
Automate the reading
Automate, then a person decides
Do it by hand
People only
Map line to pageSort into Annex IICross-read factsCompare editionsDraft N/A reasonsWhich value is rightSign the reviewAccept N/A
How much judgment it takes →

Our reading of the sources 1,2

Show the numbers
ItemHow much judgment it takes (0–1)How large and mechanical the reading is (0–1)
Map line to page0.140.74
Sort into Annex II0.140.66
Cross-read facts0.140.59
Compare editions0.140.52
Draft N/A reasons0.550.68
Which value is right0.550.32
Sign the review0.720.22
Accept N/A0.550.11
TextDoes it reach a tool that reads your own technical file?Status
MDR Articles 10 and 15Yes, in effect. The file must allow conformity to be assessed, and a named person answers for it. No tool moves that duty.1In force
ISO 13485, subclause 4.1.6Often. FDA's guidance cites this clause for validating software used as part of the quality management system for its intended use, so your procedures decide how a review tool is qualified.30ISO 13485:2016, the edition FDA's guidance cites
EU AI Act, Article 6By our reading, no high-risk route. The tool is neither a device nor a safety component of one, and reviewing your own documents is not on the Act's Annex III list of high-risk uses. Get your own legal view.31The Act's rules for AI in regulated products, listed in its own Annex I, move to August 2, 2028 under the Digital Omnibus on AI, in force July 27, 202632
FDA Computer Software AssuranceFor US-regulated makers, its scope is software used in device production or the quality management system, under 21 CFR Part 820. It offers a useful risk-based method, and it is no EU requirement.30Final, February 2026
FDA AI draft guidance, January 2025Written for drugs and biological products. It does not set the test for a device file.33Draft
European Medicines Agency (EMA) reflection paperCovers the medicinal product lifecycle.34Published September 30, 2024
EU good manufacturing practice (GMP) Annex 11, draft Annex 22Written for medicinal product manufacturing. EudraLex lists Annex 11 at its January 2011 revision and no Annex 22.35Revision and Annex 22 remain drafts
GAMP 5, ALCOA+Pharma quality practice. Some device quality teams borrow the ideas: attributable, legible, original records and risk-based validation.Industry practice

Where automated reading of a technical file falls short, and the control for each

What a model can doThe control
State a confident citation that is wrongThe citation must open the page it names
Read an out-of-date revisionThe set it reads is limited to released documents
Miss a fact phrased in an unusual wayA clean result counts only for what was checked
Fail to judge whether clinical evidence is sufficientPeople make that call

Academic critics of the MDR name "transparency, clarity, and traceability of requirements" as core principles the regulation itself falls short on.36 So traceability has to be built inside your own file.

Testing an automated file read with planted errors

  1. Take a released file you know well, and copy it.
  2. Plant known defects: a changed shelf life on one page, a swapped digit, a superseded edition, a blank reason.
  3. Count what the tool finds, what it misses, and what it flags that is correct.
  4. Run the same exercise on your manual review.

It is the only comparison we know of that is fair to both, and Part C sets it out as a pilot.

12 · How teams do it today

How regulatory teams review a technical file today: four desks, a spreadsheet, and weeks of reading

In shortA regulatory lead walks a spreadsheet checklist, asks engineers and authors for evidence, and writes the gap list. A quality manager runs change control and often reviews second. Most of the reviewer's days go to mapping lines to pages and cross-reading documents. Teams do this in house, with consultants, or with checklist software.

Regulatory lead, file author, design engineer, quality manager: who owns which question

RA

Regulatory affairs lead

Owns the checklist, every "not applicable" and the signature on the review. Often also the person responsible for regulatory compliance under Article 15.1

Cares about: no surprise from the notified body.
TF

Technical file author

Assembles Annex II, owns labels and instructions, chases translations.

Cares about: which page is wrong and what it should say.
DE

Design engineer

Owns design verification, bench tests and the aging study.

Cares about: the data behind the claim, cited correctly.
QM

Quality manager

Runs change and document control, and often reviews class III files second.

Cares about: every fix under a change record, with a version.

From released documents to a signed pre-submission review

A manual review hands off between four desks before the file goes out
  1. 1Export released file

    Pull released revisions; set drafts and old revisions aside.

    Technical file authorDays
  2. 2Walk the checklist

    Each line to its document and page, in a spreadsheet.

    Regulatory leadWeeks
  3. 3Check editions

    Each cited standard against current lists.

    Regulatory leadDays
  4. 4Ask the owners

    Gaps sent to engineers and authors by email.

    Design, labelingDays to weeks
  5. 5Fix under change control

    Each correction released as a new revision.

    Quality managerWeeks
  6. 6Write and sign

    Review report, second review, signature.

    Quality manager, regulatory leadDays

Illustrative · replace with your own numbers · A typical shape; every team differs.

Show the numbers
StepWhat happensWhoTime
Export released filePull released revisions; set drafts and old revisions aside.Technical file authorDays
Walk the checklistEach line to its document and page, in a spreadsheet.Regulatory leadWeeks
Check editionsEach cited standard against current lists.Regulatory leadDays
Ask the ownersGaps sent to engineers and authors by email.Design, labelingDays to weeks
Fix under change controlEach correction released as a new revision.Quality managerWeeks
Write and signReview report, second review, signature.Quality manager, regulatory leadDays

Mapping lines to pages takes the largest share of an estimated 30-day file read

Mapping and cross-reading take 60% of one reviewer's estimated 30 working days

An estimate for one class III file reviewed by hand, in working days

Index the file, find released revisionsMap each line to a document and pageCheck standard editionsCross-read facts between documentsReasons, gap list, report and signing
By hand, about 30 days412365

Illustrative · replace with your own numbers · An estimate for this guide's fictional company. No public figure exists; time your own.

Show the numbers
Index the file, find released revisionsMap each line to a document and pageCheck standard editionsCross-read facts between documentsReasons, gap list, report and signing
By hand, about 30 days412365

Cross-reading is usually the band that gets cut when the date is close, since nothing in a checklist forces it. And reviews stack up: at the example's six weeks a file, one reviewer needs 54 weeks for nine files due at the first deadline.

In-house spreadsheet, consultant gap assessment or checklist software

In house

Spreadsheet checklist

A template copied per device. Cheap and well understood. The weak points: links that go stale when a revision moves, no cross-reading, and one reviewer reading one file at a time.

Outsourced

Consultant gap assessment

A specialist reads the file and writes findings. Fresh eyes, often strong on clinical and biocompatibility questions. Priced per file, and the answers still come back to your owners and your change control.

Software

Checklist and quality tools

Tools that track lines, owners and templates. They organize the work, and many leave the reading and the cross-reading to the reviewer. Ask whether a tool reads the documents or only records what a person typed.

Part B · See it working

Botminds EU MDR Technical Documentation Review on a class III coronary catheter file

Part A described the work without naming a product. This part shows how Botminds does it, on a fictional maker's file. Every company, device, person, document number and figure in the screens is sample data, and dates and spellings in the screens are shown in US form. Line numbers such as 23.2 · 06 come from the sample company's own checklist template, and the Annex I summaries on the screens are the product's short wording: use Part A for the regulation's own.

13 · One file, start to finish

The Calvera NC file: 186 documents read, three contradictions decided, and a signed pre-submission review

In shortThis is the example from the top of the page, inside the product. Five agents, AI programs with one job each, sort, map and cross-read the file. Ingrid Halvorsen, the regulatory affairs lead, opens a board of Annex I sections, finds the shelf life that disagrees, decides it and assigns the change. Annika Brandt, the quality manager, reviews second, and Ingrid signs. The file goes to the notified body with its known issues owned and dated.

1

One ring per Annex I section

Ingrid opens the GSPR board for Calvera NC on Tuesday, October 13, 2026. Each ring is an Annex I section, filled as its lines gain evidence. An empty arc is a gap, a red notch a contradiction, a dashed ring a section that does not apply, and a dot a section the notified body asked about on the sister device.

The file stands at 86%: 88 of 102 applicable lines evidenced, 11 gaps, 3 contradictions, and 79 lines not applicable, all with a reason except the blank one that is gap G-05. Section 23, label and instructions for use, sits at 80% with two red notches.

The GSPR board. Annex I at a glance, with section 23 selected and its lines listed on the right. The screen's "each with a reason" has one exception, gap G-05.
2

Five agents read the released file

The file came from the document control system on October 9: 186 documents, 9,412 pages. The file indexer sorted them into Annex II and set 14 superseded revisions aside, never cited. The GSPR mapper sorted 181 lines into 102 and 79, then found evidence for 88. The standards checker compared 24 standards, the consistency checker read 8 facts in 46 places, and the review report writer drafted the report.

The run took 4 hours 12 minutes of agent time, each step listed with what it found.

The review run. Each agent's step and what it found, ending in 11 gaps and 3 contradictions for a person.
3

Eight facts, read from every document

Classification, sterilization method, shelf life, UDI-DI, Basic UDI-DI, intended purpose, storage conditions and rated burst pressure come from 46 places in 14 documents, each value with its page. Five facts agree everywhere. Three do not, and each red cell opens both pages.

Consistency across the file. Each cell is the value as written, with its page. Shelf life reads 36 months in six places and 24 in three.
4

Shelf life: two released documents, two numbers

Contradiction C-01 opens the two pages side by side. DS-114 rev C, page 12: 36 months from the date of manufacture. LA-0388 rev B, panel 2: date of manufacture plus 24 months, so lot 260914A prints 2028-09. Change record CR-0412, approved by Annika Brandt on March 18, 2025, extended the shelf life on aging report TR-2291 rev C, and it never listed the artwork or the instructions.

The agents never choose the value. Three options sit on the right: align the label and instructions to 36 months, keep 24 and correct the design file until real-time aging reads out in March 2028, or mark it not a contradiction with a written reason.

Shelf life, side by side. Both pages with the passages marked, why they differ, and the decision that belongs to the regulatory lead. For a legacy device, also confirm the notified body approved the aging protocol, as section 4 explains.
5

Decided, assigned, and signed with the open items on the report

Ingrid aligns the label and instructions to 36 months and assigns change CR-0431 to Tomás Reyes, due October 24, with Annika Brandt approving. The ring stays red until the corrected document is released. The notified body's earlier question sits beside the decision: "Provide the evidence supporting the shelf life stated on the label and confirm it is consistent with the device description."

Annika completes the second review at 10:20 am. Ingrid signs with her name, password and the meaning "Review complete, gaps assigned before submission". The two contradictions still open stay on the report as open items.

Signing the review. A signature carries a name, a time and a stated meaning, and open items stay visible.

The solution's design targets are 5 days per file review, down from about 6 weeks by hand, and no rounds of questions expected on what the review covers, down from 3 on the sister device. They are targets to measure on your own files, and clinical questions sit outside what a file read can settle.

14 · Every screen

Thirteen more screens, from a single checklist line to fourteen legacy devices

In shortOne contradiction is the story. These screens show the rest: the lines inside a section, a gap with its fix, a rejected or accepted reason, the two other contradictions, the gap list, standard editions, the file itself, the device portfolio, the drafted report and the settings that set the rules.

Lines inside a section. Each line with its document and page, or its gap, owner and reason.
After the decision. Who decided, the change raised, the earlier question, and all nine statements of the fact.
A line with its evidence. The passage, the document and where it sits. A line with no such citation stays a gap.
A gap with its fix. The report follows ISO 10993-1:2009. The sample data calls the 2020 edition current; the current, harmonized edition is EN ISO 10993-1:2025, listed since June 17, 2026.9 The fix is the same in shape: update, or justify with a gap analysis.
A reason to accept or reject. The agent drafts the "not applicable" reason. A person accepts it or marks the line applicable.
Rated burst pressure. 18 atm in the specification and bench report, 20 atm in the instructions' chart, which was rebuilt from the sister device's template.
UDI-DI. The draft declaration's last two digits are swapped, and the number fails its check digit. The sample draft also lists Annex IX Chapters I and III; a class III device goes through Chapter II as well.1
The gap list. Each gap with the line it breaks, the fix, an owner or a suggested one, a date before submission, and any earlier question. Editions in G-03 and G-06 are the sample's: see the captions above and below.
Standard editions. Edition cited against current edition, for every standard the file cites. This list is sample data and has aged: as of November 2026, EN ISO 10993-1:2025 and EN ISO 15223-1:2021 with A1:2025 are the harmonized references, and EN ISO 10555-4:2023 has replaced 2013.9,16 A live review reads current sources, refreshed monthly.
The technical file. Annex II sections with documents and pages, and each key document with its revision and how many requirements it evidences.
The legacy portfolio. Fourteen devices, deadlines and review status. By hand, one reviewer finishes the 2027 files on June 22, 2027; the design target is November 24, 2026. The screen cites the 2025 survey; the February 2026 survey reports 51% of notified bodies at 13 to 18 months and 31% at 19 to 24.4 The €62M is illustrative.
The review report. Version 0.3 of RA-REV-0388: scope, results by chapter, contradictions, gaps, standards and where questions are likely.
The review rules. Your template, what counts as evidence, the facts to cross-check, where editions come from, and who signs.

Select any screen to open it larger. The company, devices, people and figures are fictional.

15 · Agents, and who signs

File indexer to review report writer: five agents that find, and a regulatory lead who decides and signs

In shortEach agent has one job and a limit printed beside it. None of them chooses the right value in a contradiction, edits a controlled document, or signs anything. The regulatory lead decides every contradiction and accepts every "not applicable". On class III files a quality manager reviews second.

What each of the five agents does on an MDR file

File indexer

Reads every document and sorts it into the sections of Annex II, with number, title, revision, pages and release status.

Never edits or replaces a controlled document. Only released revisions count as evidence.

GSPR mapper

For each line, decides whether it applies, finds the passage that meets it, cites document, revision and page, names the standard, and drafts reasons for lines that do not apply.

Never marks a line evidenced without a page, or closes a "not applicable" without a person.

Standards checker

Lists every standard the file cites and compares each edition with the current and harmonized one.

Never decides a standard is not needed. That call is the regulatory lead's.

Consistency checker

Reads the same fact from every document that states it and shows disagreements side by side, with the change record or template history that explains them.

Never chooses which value is right.

Review report writer

Drafts the pre-submission report: results by chapter, contradictions and decisions, gaps with owners, standards out of date, and where questions are likely.

Never signs or submits. Open items stay on the report.

Two people decide, and the second one reviews class III files

Decides and signsRegulatory affairs leadDecides each contradiction, accepts or rejects each reason, and signs the review with name, time and meaning.
Second reviewQuality managerReviews class III reports before signature, approves the changes the decisions raise, and owns change control.
Owns the rulesHead of regulatory affairsOwns the checklist template, the facts to cross-check and who may sign; every change is versioned.

Versions of the checklist and report are kept, and agent steps and human decisions sit apart on the activity record. These controls support your compliance with MDR Article 15 and your quality system; the product itself holds no regulatory certification. Botminds is SOC 2 Type II audited, and manages information security to ISO 27001.

Ingrid, Tomás, Mateo and Annika on the Calvera NC file

Fictional, from the sample data
IH

Ingrid Halvorsen · regulatory affairs lead, devices

Owns 14 legacy device files and signs every pre-submission review.

"I would rather find the contradiction than have the notified body find it."
TR

Tomás Reyes · technical file author

Assembles Annex II files and owns labels and instructions.

"Tell me which page is wrong and what it should say."
ML

Mateo Lindgren · R&D design engineer, coronary catheters

Owns design verification, bench tests and the aging study.

"The data supports 36 months. The label just never caught up."
AB

Annika Brandt · quality manager

Change control, document control, second reviewer for class III.

"Every fix goes through a change record, with a version."
16 · What goes in and out

From released Annex II documents to a filled GSPR checklist, a gap list and a signed review report

In shortThe solution reads the technical documentation you already hold, against your own checklist template, and hands back a filled checklist, gaps and contradictions with owners, an edition check, and a report for your people to sign. Your document control system stays the source of truth, read only.

From your file

  • Released Annex II documents, every section
  • The current GSPR checklist
  • Label artwork and instructions for use
  • Change records

From your team

  • Your checklist template
  • The facts to cross-check
  • Notified body question history
  • Who owns what, who signs
Agents index, map, check and cross-read Every released page, against your template
The regulatory lead decides
Every line cites its page

Outputs

  • GSPR checklist filled with evidence, document and page
  • Gaps with fix, owner and date
  • Contradictions shown side by side, with the cause
  • Edition check on every standard cited
  • A signed pre-submission review report

What changes for the team

  • Lines to check, each with its page
  • Decisions already framed
  • A re-check when a document is released

Design targets for one class III file and a 14-device portfolio

The design target moves one file review from 30 working days to about 5, with the biggest saving in mapping

Working days for one class III file review

By hand (estimate)Design target
Map lines to document and page121.5
Cross-read facts between documents61
Index the file, find released revisions40.5
Check standard editions30.25
Write reasons and the gap list30.75
Draft, second review, sign21

Illustrative · replace with your own numbers · Both columns are the solution's estimates for its sample company. Measure them on your own files. The last row shrinks least, because deciding and signing are people's work.

Show the numbers
By hand (estimate)Design target
Map lines to document and page121.5
Cross-read facts between documents61
Index the file, find released revisions40.5
Check standard editions30.25
Write reasons and the gap list30.75
Draft, second review, sign21
5 days

per technical file review, down from about 6 weeks by hand.

Design target
0 rounds

of notified body questions expected on what the review covers, down from 3 on the sister device.

Design target. Clinical questions sit outside it
14 of 14

legacy devices reviewed before the 2027 deadline. The €62M a year of EU sales behind them is illustrative.

Design target

Systems a technical file review connects to

Document control or quality systemReleased documents, read only
Change controlDecisions raise changes there
Product lifecycle management (PLM)Bills of materials, specifications
Labeling systemArtwork and variable data
UDI and EUDAMED recordsIdentifiers to compare
Standards subscriptionEditions you license
Identity and accessRoles, separation of duties, sign-off
Audit exportActivity record for your auditors

For each, check whether it has an API, a file export, or only screens, and who owns it. Enterprise rollouts use roles and maker-checker sign-off, where one person prepares and another approves, across device families, with every action on the audit trail.

Your checklist template and change control stay yours

Your GSPR template

Kept as it is. The review fills your own lines and your own columns.

Your document control

It stays the source of truth. Released documents are read from it and nothing is written back.

Your change process

A decision raises a change in your process. The line stays marked until the corrected document is released.

Part C · Are you ready to automate?

Automating an MDR technical file review: what it costs you today, what it returns and how to test it

You review technical files, or manage the people who do, or answer for the devices they cover. This part is written for you: what questions and delays cost, what automating the read could return, whether your team is ready, and what to ask any vendor of GSPR checklist or review software, including us.

17 · What questions and delays cost

What a round of notified body questions costs you in reviewer weeks, billed hours and EU sales

In shortNobody publishes the cost of a round of questions, so the numbers that matter are yours. A few published figures frame them: the full cost manufacturers report for a certificate, how few files arrive complete, and how long certificates take. Most of the bill is your own people's time.

$692k

average full cost manufacturers report for a first product certificate, €616,981, against a fee of €75,532 (about $84,700).19,20

European Commission evaluation, 14 respondents
14 of 52

notified bodies say more than half of submissions are complete on arrival.4

Notified body survey, February 2026
41%

of notified bodies report more than 18 months for a certificate covering the quality system and the product.4

Notified body survey, February 2026: the 39 bodies that had issued one
Most of one round of questions lands on your own desks

Illustrative hours for one round, to show the shape. Replace every figure with your own

Regulatory lead: reading, routing, replyingEngineers and authors: evidence and reworkQuality: change control and releaseNotified body: re-read, billed to you
One round, about 240 hours601004040

Illustrative · replace with your own numbers · No regulator or survey publishes this split.

Show the numbers
Regulatory lead: reading, routing, replyingEngineers and authors: evidence and reworkQuality: change control and releaseNotified body: re-read, billed to you
One round, about 240 hours601004040
A week of sales is usually the biggest cost, and the rarest in a budget. A device selling €8.4M a year, the example's figure, earns about €160,000 a week. The arithmetic is ours and the sales figure is fictional. Use your own, and remember that the risk at the deadline is new supply: units already on the market may keep being sold.8

Finding what your own technical file reviews cost in one week

CostWhere it hidesHow to find your number in a week
Reviewer time per fileMapping lines, chasing the current revision, cross-readingAsk your last two reviewers for days by step, and time one section of the next file
Questions per fileScattered across email and notified body portalsCount questions and rounds on your last three files
Avoidable questionsMixed in with the real scientific onesMark each past question: could a reader of our own file have found this?
Hours per roundEngineers, authors and quality, none coded to the fileAsk each owner for an estimate on the last round, then add them up
Billed notified body hoursInvoices spread across a year or morePull invoices for the last file; read the body's published fee list
Change records that missed documentsFound later, as a contradiction or an audit findingPick five change records and check every document stating the changed value
Market exposureSales on legacy certificates, by deadlineList devices by deadline, sales and realistic certificate date

A lost tender, a lost reviewer and a wrong value in the field: costs beyond the calculator

The device that drops off a tenderA hospital's buyer may want the MDR certificate before the deadline arrives.
Your place in the queueTime spent on avoidable questions goes on top of a specialist's backlog.
A wrong value in the fieldA wrong rated pressure or storage condition that reaches a user is a patient safety matter first and a paperwork one second.
Knowledge that walks outWhen a reviewer leaves, the reasoning behind each line often goes too.
New product work that waitsEach engineer answering questions on an old file is off the next design.
18 · Your return

What a faster file read returns: reviewer weeks, avoided rounds and billed notified body hours

In shortPut in your own numbers. Only the notified body rate is built from published fee lists. Every default marked illustrative is an assumption to replace, and hours with automation start at the solution's design target. The calculator leaves market exposure out on purpose: enter it in your own business case.

Reviewer weeks, rounds avoided and contradictions: where a file read saves

Reviewer time

Lines to check, each with its page

Lines arrive mapped and cited, and the reviewer judges instead of searching.

files × hours saved × loaded hourly cost
Questions avoided

Fewer rounds of questions

Findings a reader of your own file could make arrive before submission.

files × rounds avoided × internal hours per round × hourly cost
Billed hours

Less re-reading at the notified body

A round avoided is also hours your notified body does not bill.

files × rounds avoided × billed hours × notified body rate
Change control

Changes that reach every document

Automated reading lists every place a fact is stated, so the next change record can name them all.

change records that later needed a second change × hours each
Portfolio speed

More files before the deadline

One team can read a portfolio inside the time the transition leaves.

files reviewed by the planned submission date, before and after
Editions

Standards checked on a schedule

Every citation is compared on each refresh, with no special project.

citations re-read per list update × minutes each

Work out your return from files a year, hours per file and your notified body's rate

The notified body default is one of the five published lists in section 9, which run from €195 to €400: €265 an hour, about $297 at the November 2, 2026 rate.23,25,20 Read your own body's list. Every input marked illustrative is an assumption.

Your volume
Hours per file
Rounds of questions
Your cost
Illustrative yearly value
Review time today, valued$0
Reviewer time released$0
Internal time on rounds avoided$0
Notified body hours not billed$0
After your yearly cost$0
Files a year to cover your cost0

Formulas, per year:
Review time today = files × hours today × hourly cost
Time released = files × (hours today − hours with automation) × hourly cost
Rounds avoided = files × rounds avoided × internal hours × hourly cost
Billed hours = files × rounds avoided × notified body hours × rate
After your cost = the three savings − yearly cost
Break-even files = yearly cost ÷ savings per file

Not counted: weeks of EU sales, delayed new products, errors reaching the field. Released hours are value only when you decide what they are for: more files before the deadline, earlier fixes, or deeper review of clinical evidence.

Each round avoided brings break-even closer: 7.9 files a year, then 3.0, then 1.9

Files a year to cover $150,000, at $95 a reviewer hour, 200 hours saved per file, 200 internal hours and 40 billed hours at $297 per round avoided

No rounds avoided, reviewer time only7.9 files
One round avoided per file3 files
Two rounds avoided per file1.9 files

Illustrative · replace with your own numbers

Show the numbers
CaseFiles a year
No rounds avoided, reviewer time only7.9 files
One round avoided per file3 files
Two rounds avoided per file1.9 files

A company with a portfolio to clear before 2027 or 2028 passes break-even quickly on these assumptions. A company reviewing one or two low-risk files a year probably does not, and should not buy on this case.

Start here19 · Readiness check

How ready your regulatory team is: portfolio, baseline, checklist discipline, controlled documents and sign-off

In shortPick the answer closest to your team today. Eight questions score 0 to 2; the last is for reflection. The meter adds up your score as you go, and each question says why it matters and what a strong answer sounds like.

1
Portfolio on legacy certificates

How many device files need review before your next notified body submission or deadline?

Why it mattersFile count against reviewer time decides whether the deadline can be met at all.
A strong answer"Fourteen legacy files, nine due by the end of 2027, in a dated list."
2
Risk class and file size

How large and complex are the files you review?

Why it mattersCross-reading pays most where many documents state the same facts, as class III and implantable files do.
A strong answer"Class III and IIb implantable, around 200 documents each."
3
Your baseline on questions

Do you know the rounds and questions on your last files, and which a reader of your own file could have caught?

Why it mattersNo public benchmark exists, so your own history is the only way to prove an improvement.
A strong answer"Three rounds, 61 questions, 23 of them about facts and editions."
4
GSPR checklist template

Is your GSPR template one controlled document, used the same way on every file?

Why it mattersA tool should fill your template. A template with several local copies has to be settled first.
A strong answer"One template, version 5, with columns for method, standard and page."
5
Released documents

Can you export one device's released revisions, complete, from one system?

Why it mattersOnly released revisions count as evidence, and scanned files or shared drives slow everything.
A strong answer"An export from our document control system by device, searchable PDFs, with an API."
6
Change control reach

When a value changes, how do you find every document that states it?

Why it mattersThis is where most contradictions start, and it tells you how much cross-reading will find.
A strong answer"We know our record has missed documents, and we want a list we can read."
7
Owner and budget

Is there one named owner of technical file quality with a budget to change the work?

Why it mattersA review crosses regulatory, design, labeling, quality and IT. Without an owner it stalls.
A strong answer"Our head of regulatory affairs sponsors it, with budget from the transition program."
8
Who signs, and quality system software

Do you have a path to qualify AI software used in your quality system, with named signers?

Why it mattersSoftware used in the quality system falls under your own procedures, and Article 15 keeps the duty with a named person.1,30
A strong answer"Quality has a risk-based software qualification procedure, and the lead signs each review."
9
Looking at your next submission · for reflection

If your notified body opened any ten checklist lines tomorrow, what would have to be true for a stranger to reach the proof in under a minute each?

Why it mattersYour answer lists the gaps. Each gap is a candidate job for software: sorting, mapping, comparing or drafting.
A strong answerA short, specific list, for example: "a page for each line, one set of values, no blank reasons, and current editions."

A low score means settling one GSPR template and counting past questions first

0–6

Explore

Build the baseline first: count questions on your last files, settle one checklist template, and name an owner. Start narrow, for example with an edition check on every file.

7–11

Ready to pilot

Run a measured pilot on one or two released files, with a copy carrying defects you planted. Compare finds, false alarms and reviewer days with your current process, and keep your people signing.

12–16

Ready to implement

Plan the portfolio: your template and rules as settings, roles and second review, document control links, re-checks on release, and the evidence your own auditors will ask for.

20 · Questions for any vendor

What to ask GSPR checklist software or an MDR review service about citations, contradictions and your template

In shortAsk every vendor the same questions, us included. The answers show whether a tool reads your documents or tracks what people type, how it cites, what it does when two documents disagree, whose rules apply and how you would test it on your own file.

AskA good answerA warning sign
What it reads
Does it read every document in the file, or track a checklist people fill in?Reads all of them, and shows what it read"You upload the evidence link"
How does it keep drafts and superseded revisions out of the evidence?Reads them and never cites them; shows them set asideNo idea of revision status
Can it read scanned pages, tables, label artwork and compliance charts?Yes, with the page shown for each valuePlain text only
Citations
Does every evidenced line cite document, revision and page, and does the citation open it?Yes, in one clickA document name, or a confidence score
What happens to a line with no page?It stays a gapFilled with prose
Who accepts a "not applicable" reason?A named person; show me one rejectedAccepted automatically
Contradictions and editions
Can it read one fact from every document, and show two pages side by side?Yes, with the change record that explains itEach document reviewed on its own
Can we add our own facts to cross-check?Yes, from settingsA fixed list
Does it ever choose which value is right?Never. It frames the decision for a personIt "auto-corrects"
Where do editions come from, and how fresh are they? Show me EN ISO 10993-1 today.A named source and refresh date; 2025 as the listed editionA list nobody dates
Does it help test a shelf-life change against MDCG 2020-3 on a legacy device?It surfaces the question for the regulatory leadTreats the fix as paperwork
Your template and control
Does it fill our template, or ask us to adopt its own?Yours, line for lineA mapping between two checklists to maintain
What does it write back to our document control system?NothingIt edits documents
What happens to an open contradiction at signature?It stays on the report as an open itemIt disappears
What is recorded, and for how long?Each step and decision, with who and when, exportableOnly the final report
Your data and AI
Which models do you use, where do they run, and does our data train them?Named models, a region you choose, no training on your data, in writing"Proprietary AI", no more detail
Which credentials do you hold, exactly?Named audits such as SOC 2 Type II; no claim of MDR, ISO 13485 or "AI Act" certification for the tool itself"Certified MDR compliant software"
What will you give our quality team to qualify the software?Intended use, test evidence and change notices"You won't need that"
Proof
Can we test it on our own file, with defects we plant, before we sign?Yes, blind, with clean copies to count false alarmsDemo files only
What will you report from the test?Finds by defect type with the number planted, false alarms, reviewer minutesOne accuracy percentage

We found no published independent test of any GSPR or technical file review tool's accuracy, as of November 2026. A planted-defect test on your own file is the fairest comparison, and it measures your current process too.

21 · How to start

Test a technical file review tool on one released file with planted defects, then decide on three numbers

In shortCount your past questions first, then test on your own file with defects you planted, then decide with three numbers. None of these steps commits you to a vendor.

  1. Classify past questions on your last three files: which could a reader of your own file have caught?
  2. Time one manual review by step, or reconstruct the last one with its reviewer.
  3. Choose a released file near your largest size, and get an approval path to share it. Copy it and plant 20 known defects.
  4. Run in parallel on your next live file, with your regulatory lead deciding and signing.
  5. Decide with three numbers: finds by defect type, false alarms on the clean file, and reviewer days to a signed review.
A ten-week pilot ends with a decision on three numbers
Your teamVendor
Classify questions; time a manual review
Choose a file; plant 20 defects in a copy
Load template, rules and facts
Read the test file blind
Parallel run on one live file
Score finds, false alarms, days
Decide
Week 03610

Illustrative · replace with your own numbers

Show the numbers
ActivityFromTo
Classify questions; time a manual review02
Choose a file; plant 20 defects in a copy13
Load template, rules and facts24
Read the test file blind35
Parallel run on one live file48
Score finds, false alarms, days79
Decide910

Finds by defect type, false alarms and page accuracy on a planted-defect file

MeasureHowWhy
Finds by defect typeFound ÷ planted, for contradictions, gaps, old editions and blank reasonsOne percentage hides the cross-document misses
False alarmsFlags on the clean file, in reviewer minutesA tool that flags everything finds every plant
Citation accuracy300 random citations opened and checkedNone wrong in 300 bounds the rate near 1% at 95% confidence
Reviewer daysFrom opening the file to a signed reviewThe cost case rests on it
Questions on the next fileRounds and questions, by type, against your baselineThe outcome you care about, a year later
The full working-session questions: 21 questions in seven groups

Bring regulatory, design, labeling, quality, clinical and IT into one room. Each question says why it matters, what a strong answer looks like, and the warning sign.

A

Legacy devices, deadlines and submission dates

A1

Which devices rely on Article 120, and do we hold the 2024 application and agreement for each?

Why it mattersThose dates cannot be repaired now.8
Strong answer · warning sign
A list with both documents.
"Regulatory has them somewhere."
A2

What certificate date has our notified body given for each?

Why it mattersSurvey bands are no substitute for your own date.
Strong answer · warning sign
A date, with assumptions.
"Probably next year."
A3

Which file goes first, and on what ranking?

Why it mattersDeadline, sales and risk rarely agree.
Strong answer · warning sign
A written order.
Whoever shouts.
B

GSPR template and the rules of evidence

B1

Who owns the GSPR template, and which version is live?

Why it mattersSoftware fills one template.
Strong answer · warning sign
One owner, versioned.
Copies per file.
B2

Does every line cite document, revision and page today?

Why it mattersTeam-NB ties precision to assessment speed.2
Strong answer · warning sign
A sampled measure.
"Mostly."
B3

Who may accept a "not applicable"?

Why it mattersThis rule becomes a setting.
Strong answer · warning sign
A named role.
The author alone.
C

Past questions and rounds from notified bodies

C1

How many rounds and questions on the last three files?

Why it mattersNo public benchmark exists.
Strong answer · warning sign
Counted by file.
Lost in email.
C2

Which of them could a reader of our own file have found?

Why it mattersIt sizes what a pre-submission read can move.
Strong answer · warning sign
Classified with a count.
"They are all scientific."
C3

Can the history be imported, to mark where questions are likely?

Why it mattersReviewers tend to ask the same things again.
Strong answer · warning sign
A structured list.
PDF letters only.
D

Change records and duplicated facts

D1

Which facts must never disagree on our devices?

Why it mattersThey become the cross-check list.
Strong answer · warning sign
Ten named facts.
"All of them."
D2

Pick five change records. Did each reach every document stating the value?

Why it mattersThe cheapest way to size the problem.
Strong answer · warning sign
Done, with misses listed.
"Our process covers that."
D3

How do we test a change against MDCG 2020-3 on a legacy device?

Why it mattersA wrong call can end the transition for that device.6
Strong answer · warning sign
A written step in change control.
Judged case by case.
E

Standards list and edition checks

E1

Is there one list of every standard our files cite, with dates?

Why it mattersThe harmonized list has been amended ten times in five years.5
Strong answer · warning sign
One list, reviewed monthly.
One per file.
E2

Have we assessed EN ISO 10993-1:2025 and EN ISO 15223-1 with A1:2025?

Why it mattersBoth moved in June 2026.9
Strong answer · warning sign
Written gap analyses.
Not heard of them.
E3

Which standards do we license, and can a tool read them?

Why it mattersStandards are copyright material.
Strong answer · warning sign
A license check.
Unknown.
F

Document control, software qualification and a sponsor

F1

How do we export released revisions, and in what state are the PDFs?

Why it mattersTeam-NB asks for searchable, bookmarked PDFs anyway.2
Strong answer · warning sign
A clean export by device.
Scans of scans.
F2

What does quality need to qualify software that touches the quality system?

Why it mattersISO 13485 subclause 4.1.6 reaches such software.30
Strong answer · warning sign
A risk-based procedure.
First time anyone asked.
F3

Who sponsors the change, and what budget can move?

Why it mattersA pilot without a sponsor ends as a demo.
Strong answer · warning sign
A named executive.
No sponsor.
G

A contradiction found the day a document is released

G1

What if the file were re-read each time a document was released?

Why it mattersTests appetite for continuous checks.
Strong answer · warning sign
"Change control would use it."
"We only review before submission."
G2

What if every checklist line opened at its page?

Why it mattersLinks review to audits and the next certificate.
Strong answer · warning sign
Internal audit would test more lines.
Nobody would look.
G3

Which steps would we never let software do without a person?

Why it mattersTells you where the signatures belong.
Strong answer · warning sign
Choosing a value, accepting reasons, signing, changing documents.
"All of it": then start with sorting and edition checks.
22 · Frequently asked questions

MDR technical documentation questions answered: GSPR, legacy deadlines, editions, timelines and AI

In shortThe questions regulatory teams and buyers search for most, each answered on its own.

What is MDR technical documentation?

MDR technical documentation is the written proof, required by Annex II of Regulation (EU) 2017/745, that a medical device meets the general safety and performance requirements of Annex I. It has six sections: device description, information supplied, design and manufacture, the requirements themselves, benefit-risk and risk management, and verification and validation. The manufacturer keeps it current, and a notified body assesses it for most devices above the lowest risk class.

What is a GSPR checklist?

A GSPR checklist is the table most manufacturers use to meet Annex II section 4. For each Annex I requirement it records whether the requirement applies, why not if it does not, the method used, the standard applied, and the controlled document that proves it. The regulation sets the content and no official template exists, so each company's line count is its own.

How many GSPRs are there in MDR Annex I?

Annex I has three chapters and 23 numbered sections: sections 1 to 9 are general, 10 to 22 cover design and manufacture, and section 23 covers the label and instructions for use. These sections hold many separate duties, so checklists can run to well over a hundred lines. No official count of requirements exists.

What is the difference between a technical file and a GSPR checklist?

The technical file is the whole of the technical documentation, which can run to hundreds of documents. The GSPR checklist is one part of it, in section 4 of Annex II, and it points from each requirement to the evidence elsewhere in the file. Notified bodies say a simple collection of test reports does not show compliance, so the checklist's links matter.

What is the EU MDR deadline for legacy devices?

Under Regulation (EU) 2023/607, class III devices and most implantable class IIb devices have until December 31, 2027. Other class IIb, class IIa, and class I sterile or measuring devices have until December 31, 2028. Both dates depend on conditions, including an application by May 26, 2024, a written agreement by September 26, 2024, and no significant change in design or intended purpose.

What happens if an MDR certificate does not arrive by the deadline?

The device may no longer be placed on the EU market on the strength of the old certificate, so new supply stops until the MDR certificate issues. Units already placed on the market may continue to be made available or put into service without a time limit, subject to their shelf life or expiry date. The Commission's Q&A on Regulation (EU) 2023/607 explains this.

How long does MDR certification take?

In the European Commission's survey with data to February 28, 2026, of the 39 notified bodies that had issued a new certificate covering the quality system and the product, 51% reported 13 to 18 months, 31% reported 19 to 24 months, 10% more than 24, and 8% 6 to 12. The clock runs from the written agreement to issue. Ask your own notified body for a date, because bands vary by device and how fast you answer questions.

How much does EU MDR certification cost?

The Commission's 2025 evaluation reports an average full cost of €616,981 (about $692,000) for a first product certificate and €385,617 (about $432,500) for a most recent one, from small samples of manufacturers. Notified bodies reported average fees of €75,532 and €68,309 for the same certificates. The difference is the manufacturer's own documentation, clinical data and staff time.

Which edition of a standard should I cite in an MDR technical file?

Cite the edition you actually applied, then state how it stands against the edition on the harmonized list and the newest published edition. The listed edition gives a presumption of conformity; the most recent published edition reflects the state of the art, according to the Commission's position in MDCG 2021-5. If you use an older edition, Team-NB expects a gap analysis and a justified conclusion.

Is EN ISO 10993-1:2025 harmonized under the MDR?

Yes. Implementing Decision (EU) 2026/1231, adopted June 11, 2026 and published June 17, 2026, added EN ISO 10993-1:2025 to the MDR list. No earlier edition of that part appeared on the list. A biological evaluation written to an older edition needs an update or a written gap and impact assessment.

What is the difference between shelf life and lifetime of a medical device?

Shelf life is how long a device can be stored and still be safe and work as intended when used; it needs aging studies and appears on the label. Lifetime is how long it goes on working safely in use; it needs fatigue, wear or clinical evidence. Team-NB states that product lifetime should not be considered equivalent to shelf life.

Is extending the shelf life of a legacy device a significant change?

It depends on the protocol. MDCG 2020-3 Rev.1 lists an extension validated by protocols approved by the notified body as non-significant, and an extension of labeled shelf life not validated against such protocols as significant. Check this before moving the printed date, record the reasoning in the change record, and ask your notified body when unsure.

How do you mark a GSPR as not applicable?

Write the reason on the line itself, tied to a property of the device or its intended purpose: for example, "not an active device; inflation is by a separate manual inflation device". Annex II asks for an explanation of why requirements do not apply, and Team-NB lists a blank reason among its common pitfalls. "No testing performed" is a gap, and it should be treated as one.

Can AI fill in a GSPR checklist?

AI can propose each line: whether it applies, the passage that meets it with document, revision and page, the standard, and a drafted reason for a line that does not apply. A named person should accept or reject each reason and decide any contradiction, because MDR Article 15 keeps responsibility with the person responsible for regulatory compliance. Test any tool on your own file with planted defects first.

Is an AI tool that reviews a technical file high-risk under the EU AI Act?

On our reading of Article 6 of the EU AI Act, no: such a tool is neither a medical device nor a safety component of one, and reviewing a maker's own documents is not on the Act's Annex III list of high-risk uses. Classification follows the intended purpose you assign, so ask your own counsel. The Act's rules for AI in regulated products, listed in its own Annex I, were moved to August 2, 2028 by the Digital Omnibus on AI, in force since July 27, 2026.

23 · One-page summary

MDR technical file review on one page: the method, the November 2026 rules, readiness and terms

Print this page

In shortThe whole guide on one screen: the method, the rules as of November 2026, the readiness questions and the terms.

The method
  1. Pull released revisions only; set drafts and old revisions aside.
  2. For each Annex I line: applies or not, reason, method, standard, document, revision, page.
  3. Check each cited edition against the harmonized list and the newest published one.
  4. Read each key fact from every document that states it, and set disagreements side by side.
  5. Decide each one, test legacy changes against MDCG 2020-3, and fix under change control.
  6. Write the report; second review; sign with open items showing.

Readiness: score 0–2 on eight questions: 0–6 explore · 7–11 pilot · 12–16 implement.

As of November 2026: legacy deadlines December 31, 2027 and 2028 · notified bodies: 51% at 13–18 months, 31% at 19–24 · EN ISO 10993-1:2025 listed June 17, 2026 · Team-NB Version 4, April 21, 2026 · EUDAMED four modules mandatory from May 28, 2026 · the December 2025 reform proposal, COM(2025) 1023, still not law.

14 terms
MDR
Regulation (EU) 2017/745, the EU's medical device law.
GSPR
A general safety and performance requirement of Annex I.
Technical file
The Annex II documentation proving a device meets them.
Notified body
The independent organization that assesses and certifies.
Legacy device
A device still sold on an old directive certificate, on conditions.
Significant change
A change in design or purpose that ends the transition.
Harmonized standard
A European standard listed in the Official Journal; gives presumption of conformity.
State of the art
What the most recent published editions reflect.
Basic UDI-DI
The identifier of a device family in the file and EUDAMED.
UDI-DI
The identifier of one device model in its barcode.
IFU
Instructions for use.
Shelf life
How long a stored device stays safe and working.
Rated burst pressure
The balloon pressure a user must not exceed.
EUDAMED
The EU's medical device database.
24 · Sources

Sources

Accessed November 2026. Regulatory status statements are as of November 2026. Euro figures are as published; dollar equivalents use the European Central Bank reference rate of $1.1216 per euro on November 2, 2026.

  1. Regulation (EU) 2017/745 on medical devices (MDR), including Annexes I, II, VII, VIII and IX, Official Journal of the European Union. eur-lex.europa.eu
  2. Team-NB, "Best Practice Guidance for the Submission of Technical Documentation under Annex II and III of Medical Device Regulation (EU) 2017/745", Version 4, adopted April 21, 2026. team-nb.org
  3. Stange A.F. and Julian E., "Conformity Assessment of Medical Devices: An Overview from a Notified Body", Journal of Market Access & Health Policy 14(1):4, January 8, 2026. pmc.ncbi.nlm.nih.gov
  4. European Commission (DG SANTE), Austrian National Public Health Institute, Areté and Civic Consulting, "Survey results of the 20th NB survey (MDR/IVDR)", data status February 28, 2026. health.ec.europa.eu
  5. European Commission, "Harmonised standards" for medical devices: the list of implementing decisions, latest dated June 11, 2026. health.ec.europa.eu
  6. Medical Device Coordination Group, MDCG 2020-3 Rev.1, "Guidance on significant changes regarding the transitional provision under Article 120 of the MDR". health.ec.europa.eu
  7. Regulation (EU) 2023/607 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions, March 15, 2023. eur-lex.europa.eu
  8. European Commission, "Extension of the MDR transitional period and removal of the 'sell off' periods: Q&A on practical aspects related to the implementation of Regulation (EU) 2023/607". health.ec.europa.eu
  9. Commission Implementing Decision (EU) 2026/1231 of June 11, 2026, amending Implementing Decision (EU) 2021/1182, published June 17, 2026, and its corrigendum. eur-lex.europa.eu
  10. European Commission, COM(2025) 1023 final, proposal for a regulation simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, December 16, 2025. health.ec.europa.eu
  11. European Parliament, Legislative Observatory, procedure 2025/0404(COD): status, committee documents and the indicative plenary date, read November 2026. oeil.europarl.europa.eu
  12. European Commission, EUDAMED overview: four modules mandatory from May 28, 2026 under Commission Decision (EU) 2025/2371. health.ec.europa.eu
  13. European Commission, "Transition period: devices and certificates registration" timeline, and Q&A on the gradual roll-out of Eudamed, question 7. timeline, Q&A
  14. Medical Device Coordination Group, MDCG 2019-07 Rev.1, "Guidance on Article 15 ... on a person responsible for regulatory compliance", December 2023, quoting Article 15(3)(b). health.ec.europa.eu
  15. Medical Device Coordination Group, MDCG 2021-5 Rev. 1, "Guidance on standardisation for medical devices", July 2024. health.ec.europa.eu
  16. Swedish Institute for Standards, SS-EN ISO 10555-4:2024, the Swedish adoption of EN ISO 10555-4:2023, Intravascular catheters: balloon dilatation catheters. sis.se
  17. ASTM International, ASTM F1980-21, Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices. store.astm.org
  18. GS1 US, "Check Digit Calculator". gs1us.org
  19. European Commission, SWD(2025) 1051 final, "Evaluation on the Targeted evaluation of Regulation (EU) 2017/745 ... and Regulation (EU) 2017/746", December 16, 2025. health.ec.europa.eu
  20. European Central Bank, euro foreign exchange reference rate, US dollar, November 2, 2026. ecb.europa.eu
  21. Institut pro testování a certifikaci, a.s. (NB 1023), "List of NB 1023 Standard Fees". medical-devices.itczlin.cz
  22. ICIM S.p.A. (NB 0425), "List of Standard Fees for Conformity Assessment Activities under the MDR", December 2025 upload. icimgroup.com
  23. Czech Metrology Institute (NB 1383), MDR price list 26-001. cmi.gov.cz
  24. SIQ Ljubljana, "Fees for conformity assessment according to Regulation (EU) 2017/745", March 2025 upload. siq.si
  25. Kiwa Belgelendirme Hizmetleri (NB 1984), "2017/745 EU MDR Price List", MDR.LS.005 R06, May 29, 2025. kiwa.com
  26. Medical Device Coordination Group, MDCG 2023-2, the template for notified bodies' lists of standard fees. health.ec.europa.eu
  27. Medical Device Coordination Group, MDCG 2019-6 Rev.5, "Questions and answers: Requirements relating to notified bodies", February 2025. health.ec.europa.eu
  28. European Commission, "Rules of Procedure of the European Commission Expert Panels on Medical Devices (EXPAMED)", section on clinical evaluation consultation timelines. health.ec.europa.eu
  29. Medical Device Coordination Group, MDCG 2021-24 Rev.1, "Guidance on classification of medical devices", Rule 6. health.ec.europa.eu
  30. US Food and Drug Administration, "Computer Software Assurance for Production and Quality Management System Software", final guidance, February 2026. fda.gov
  31. Regulation (EU) 2024/1689 (AI Act), Article 6 and Annex I. eur-lex.europa.eu
  32. Lewis Silkin, "The Digital Omnibus on AI enters into force today", July 27, 2026, with the Official Journal reference L 2026/1744. lewissilkin.com
  33. US Food and Drug Administration, "Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products", draft guidance, January 2025. fda.gov
  34. European Medicines Agency, "Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle", published September 30, 2024. ema.europa.eu
  35. European Commission, EudraLex Volume 4, EU GMP guidelines: annex list, read November 2026. health.ec.europa.eu
  36. Haimerl M., D'Agosto M., Fornefett M., Kubon M. and Schiepp T., "Deficiencies of the EU Medical Device Regulation when applying its own rules", Frontiers in Medicine 12:1732399, January 21, 2026. pmc.ncbi.nlm.nih.gov
Next step

See it on your own technical file.

Explore the solution, or bring one released technical file and your GSPR template, and we will read it with you: every line tied to its document and page, every fact that disagrees shown side by side, and your regulatory lead deciding.

botminds.ai The complete guide to EU MDR technical documentation review · November 2026. Corvane Medical, Calvera NC, Calvera SC, every other device, person, document number and figure in the example and the screens are fictional. Regulatory status is as of November 2026; check the sources before relying on it. General information only; take legal advice for your own devices.